Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: Detection via localized proton spectroscopy
John Kurhanewicz, Daniel B. Vigneron, Sarah J. Nelson, Hedvig Hricak, Jeffrey M. MacDonald, Badrinath Konety, Perinchery Narayan
Dive into the research topics of 'Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: Detection via localized proton spectroscopy'. Together they form a unique fingerprint.